id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2004-E-0266-0003,FDA,FDA-2004-E-0266,NPS Pharmaceticals Inc. and Brigham and Women's Hospital - Patent Term Extension Application,Other,APP-Application,2008-10-23T04:00:00Z,2008,10,2008-10-23T04:00:00Z,,2013-07-27T20:49:47Z,,0,0,09000064804721c7
FDA-2004-E-0266-0004,FDA,FDA-2004-E-0266,U.S. Patent and Trademark Office  to FDA - Letter,Other,LET-Letter,2008-10-23T04:00:00Z,2008,10,2008-10-23T04:00:00Z,,2008-10-23T13:20:00Z,,0,0,0900006480774637